Psychedelic use in clinical settings is emerging as a way to treat a variety of psychiatric illnesses. However, psychedelic use primarily occurs in recreational settings, and the absence of standard protocols elevates the risk of users experiencing adverse reactions or "bad trips." This article discusses the use of and risks associated with "trip killers" or "trip sitters," and key considerations for nurses when caring for patients who use any of these drugs.
No takes yet. Share an insight, caveat, or question.
Maria Wheeler (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: